Bogusz Aksak-Wąs, Karolina Skonieczna-Żydecka, Danuta Cembrowska-Lech, Miłosz Parczewski, Rafał Hrynkiewicz, Filip Lewandowski, Karol Serwin, Kaja Mielczak, Mateusz Bruss, Franciszek Lenkiewicz, Paulina Niedźwiedzka-Rystwej
{"title":"Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern.","authors":"Bogusz Aksak-Wąs, Karolina Skonieczna-Żydecka, Danuta Cembrowska-Lech, Miłosz Parczewski, Rafał Hrynkiewicz, Filip Lewandowski, Karol Serwin, Kaja Mielczak, Mateusz Bruss, Franciszek Lenkiewicz, Paulina Niedźwiedzka-Rystwej","doi":"10.1007/s12026-026-09817-8","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic viral coinfections may contribute to persistent immune dysregulation in people with HIV, but their association with PD-1/PD-L1 expression remains uncertain. We analysed 100 people with HIV using available-case endpoint analyses and marker-specific paired baseline-to-follow-up analyses. Follow-up was scheduled at 12 months (allowable window, 9-15 months), and all participants had HIV RNA < 50 copies/mL at the endpoint. Baseline HBV contact, HCV status, and CMV IgG serostatus were evaluated in relation to PD-1 and PD-L1 expression on CD4⁺ T cells and CD19⁺ B cells and exploratory composite checkpoint-expression indices. HBV contact and CMV IgG serostatus were not associated with reproducible differences. The global comparison of longitudinal CD4⁺ T-cell PD-L1 change across HCV groups did not remain significant after false-discovery-rate correction; an exploratory pairwise comparison suggested a greater increase in participants with baseline HCV RNA positivity. Overall, the HCV-related pattern was hypothesis-generating and requires prospective validation.</p>","PeriodicalId":13389,"journal":{"name":"Immunologic Research","volume":"74 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13461818/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunologic Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12026-026-09817-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic viral coinfections may contribute to persistent immune dysregulation in people with HIV, but their association with PD-1/PD-L1 expression remains uncertain. We analysed 100 people with HIV using available-case endpoint analyses and marker-specific paired baseline-to-follow-up analyses. Follow-up was scheduled at 12 months (allowable window, 9-15 months), and all participants had HIV RNA < 50 copies/mL at the endpoint. Baseline HBV contact, HCV status, and CMV IgG serostatus were evaluated in relation to PD-1 and PD-L1 expression on CD4⁺ T cells and CD19⁺ B cells and exploratory composite checkpoint-expression indices. HBV contact and CMV IgG serostatus were not associated with reproducible differences. The global comparison of longitudinal CD4⁺ T-cell PD-L1 change across HCV groups did not remain significant after false-discovery-rate correction; an exploratory pairwise comparison suggested a greater increase in participants with baseline HCV RNA positivity. Overall, the HCV-related pattern was hypothesis-generating and requires prospective validation.
期刊介绍:
IMMUNOLOGIC RESEARCH represents a unique medium for the presentation, interpretation, and clarification of complex scientific data. Information is presented in the form of interpretive synthesis reviews, original research articles, symposia, editorials, and theoretical essays. The scope of coverage extends to cellular immunology, immunogenetics, molecular and structural immunology, immunoregulation and autoimmunity, immunopathology, tumor immunology, host defense and microbial immunity, including viral immunology, immunohematology, mucosal immunity, complement, transplantation immunology, clinical immunology, neuroimmunology, immunoendocrinology, immunotoxicology, translational immunology, and history of immunology.